Literature DB >> 28194475

Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?

A D Dede1, G Trovas2, E Chronopoulos3, I K Triantafyllopoulos2, I Dontas2, N Papaioannou2, S Tournis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28194475     DOI： 10.1007/s00198-017-3927-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  9 in total

1.  A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?

Authors:  A Morton
Journal:  Osteoporos Int       Date:  2017-02-13       Impact factor: 4.507

2.  Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria.

Authors:  Víctor García-Nieto; Margarita Monge-Zamorano; Montserrat González-García; María Isabel Luis-Yanes
Journal:  Pediatr Nephrol       Date:  2011-08-28       Impact factor: 3.714

Review 3.  Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.

Authors:  Howard A Fink; Timothy J Wilt; Keith E Eidman; Pranav S Garimella; Roderick MacDonald; Indulis R Rutks; Michelle Brasure; Robert L Kane; Jeannine Ouellette; Manoj Monga
Journal:  Ann Intern Med       Date:  2013-04-02       Impact factor: 25.391

Review 4.  Thiazide diuretics and the risk of hip fracture.

Authors:  Koko Aung; Thwe Htay
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

5.  The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women.

Authors:  M J Bolland; R W Ames; A M Horne; B J Orr-Walker; G D Gamble; I R Reid
Journal:  Osteoporos Int       Date:  2006-11-21       Impact factor: 4.507

6.  Optimal age of commencing and discontinuing thiazide therapy to protect against fractures.

Authors:  C Kruse; P Eiken; P Vestergaard
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

7.  Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis.

Authors:  Miguel Angel Arrabal-Polo; Salvador Arias-Santiago; Tomas de Haro-Muñoz; Adriana Lopez-Ruiz; Jacinto Orgaz-Molina; Samuel Gonzalez-Torres; Armando Zuluaga-Gomez; Miguel Arrabal-Martin
Journal:  Urology       Date:  2013-01-30       Impact factor: 2.649

8.  Continuous and long-term treatment is more important than dosage for the protective effect of thiazide use on bone metabolism and fracture risk.

Authors:  C Kruse; P Eiken; P Vestergaard
Journal:  J Intern Med       Date:  2015-07-30       Impact factor: 8.989

Review 9.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.